Your browser doesn't support javascript.
Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
Koong, Lin Ru; Chee, Wai Kitt; Toh, Zhi Hong; Ng, Xin Le; Agrawal, Rupesh; Ho, Su Ling.
  • Koong LR; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.
  • Chee WK; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.
  • Toh ZH; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.
  • Ng XL; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.
  • Agrawal R; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.
  • Ho SL; Lee Kong Chian School of Medicine, Singapore.
Ocul Immunol Inflamm ; 29(6): 1212-1215, 2021 Aug 18.
Article in English | MEDLINE | ID: covidwho-1402198
ABSTRACT
A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Uveomeningoencephalitic Syndrome / Vaccination / SARS-CoV-2 / COVID-19 / BNT162 Vaccine Type of study: Case report / Diagnostic study / Prognostic study Topics: Vaccines Limits: Humans / Male / Middle aged Language: English Journal: Ocul Immunol Inflamm Journal subject: Allergy and Immunology / Ophthalmology Year: 2021 Document Type: Article Affiliation country: 09273948.2021.1974492

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Uveomeningoencephalitic Syndrome / Vaccination / SARS-CoV-2 / COVID-19 / BNT162 Vaccine Type of study: Case report / Diagnostic study / Prognostic study Topics: Vaccines Limits: Humans / Male / Middle aged Language: English Journal: Ocul Immunol Inflamm Journal subject: Allergy and Immunology / Ophthalmology Year: 2021 Document Type: Article Affiliation country: 09273948.2021.1974492